SCHEMBL21446672

SCHEMBL21446672

c1ccc(N(c2ccccc2)c2ccc3c(c2)C2(c4ccccc4-c4ccccc42)c2cc4cc(N(c5ccccc5)c5ccccc5)ccc4cc2-3)cc1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 6/20 0.40
▸ KDM4E B2RXH2 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ MEN1 O00255 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ OPRK1 P41145 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23597912 1.00 PDK2 (0.40) PDK2KDM4EMAPTALDH1A1CYP1A2
SCHEMBL13341834 0.97 PDK2 (0.39) PDK2KDM4EMAPTALDH1A1CYP1A2
SCHEMBL21446682 0.97 KDM4E (0.38) PDK2KDM4EMAPTALDH1A1CYP1A2
SCHEMBL20736793 0.97 KDM4E (0.38) PDK2KDM4EMAPTALDH1A1CYP1A2
SCHEMBL19797202 0.96 PDK2 (0.39) PDK2KDM4EMAPTALDH1A1CYP1A2
SCHEMBL19822140 0.96 PDK2 (0.39) PDK2KDM4EMAPTALDH1A1CYP1A2
SCHEMBL20736208 0.96 ALDH1A1 (0.37) PDK2KDM4EMAPTALDH1A1CYP1A2
SCHEMBL20737888 0.96 ALDH1A1 (0.37) PDK2KDM4EMAPTALDH1A1CYP1A2
SCHEMBL23597988 0.95 KDM4E (0.39) PDK2KDM4EMAPTALDH1A1CYP1A2
SCHEMBL23597916 0.95 KDM4E (0.39) PDK2KDM4EMAPTALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220140247-A1 PLURALITY OF HOST MATERIALS, COMPOSITION COMPRISING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2022-05-05 — — US disclosed
US-20220037596-A1 PLURALITY OF LIGHT-EMITTING MATERIALS, ORGANIC ELECTROLUMINESCENT COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT 2022-02-03 — — US disclosed
WO-2019194616-A1 AMINE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME 주식회사 엘지화학 2019-10-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220037596-A1 PLURALITY OF LIGHT-EMITTING MATERIALS, ORGANIC ELECTROLUMINESCENT COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ELAVL1, EML4, NECTIN4 PDK2 1625/4885KDM4E 3028/4885MAPT 699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback